Novel antiviral activity of chemokines

Virology

Volumn 350, Issue 2, 2006, Pages 484-492

  Nakayama, Takashi ^a   Shirane, Jumi ^a   Hieshima, Kunio ^a   Shibano, Michiko ^a   Watanabe, Masayasu ^a   Jin, Zhe ^a   Nagakubo, Daisuke ^a   Saito, Takuya ^b   Shimomura, Yoshikazu ^a   Yoshie, Osamu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

Antimicrobial peptides; Antiviral; Chemokines; gB; HSV 1

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; THROMBOSPONDIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CHANNEL GATING; CONTROLLED STUDY; EFFECTOR CELL; ELECTRON MICROSCOPY; HERPES SIMPLEX VIRUS 1; HOST RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRION;

ANTIVIRAL AGENTS; CHEMOKINES; HERPESVIRUS 1, HUMAN; HUMANS; MICROSCOPY, ELECTRON; RECOMBINANT PROTEINS; VIRION;

FUNGI; HUMAN HERPESVIRUS 1;

EID: 33745259497     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.03.004     Document Type: Article

References (52)

1. Amara A., Gall S.L., Schwartz O., Salamero J., Montes M., Loetscher P., Baggiolini M., Virelizier J.L., and Arenzana-Seisdedos F. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186 1 (1997) 139-146
2. Bishop G.A., Marlin S.D., Schwartz S.A., and Glorioso J.C. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. J. Immunol. 133 4 (1984) 2206-2214
3. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., and Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382 6594 (1996) 829-833
4. Bodaghi B., Jones T.R., Zipeto D., Vita C., Sun L., Laurent L., Arenzana-Seisdedos F., Virelizier J.L., and Michelson S. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J. Exp. Med. 188 5 (1998) 855-866
5. Catalfamo M., Karpova T., McNally J., Costes S.V., Lockett S.J., Bos E., Peters P.J., and Henkart P.A. Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity 20 2 (2004) 219-230
6. Chang T.L., Vargas Jr. J., DelPortillo A., and Klotman M.E. Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J. Clin. Invest. 115 3 (2005) 765-773
7. Clayberger C., and Krensky A.M. Granulysin. Curr. Opin. Immunol. 15 5 (2003) 560-565
8. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., and Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270 5243 (1995) 1811-1815
9. Cole A.M., Ganz T., Liese A.M., Burdick M.D., Liu L., and Strieter R.M. Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J. Immunol. 167 2 (2001) 623-627
10. Daher K.A., Selsted M.E., and Lehrer R.I. Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60 3 (1986) 1068-1074
11. De Y., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., Oppenheim J.J., and Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192 7 (2000) 1069-1074
12. Dorner B.G., Scheffold A., Rolph M.S., Huser M.B., Kaufmann S.H., Radbruch A., Flesch I.E., and Kroczek R.A. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc. Natl. Acad. Sci. U.S.A. 99 9 (2002) 6181-6186
13. Dorner B.G., Smith H.R., French A.R., Kim S., Poursine-Laurent J., Beckman D.L., Pingel J.T., Kroczek R.A., and Yokoyama W.M. Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection. J. Immunol. 172 5 (2004) 3119-3131
14. D'Souza M.P., and Harden V.A. Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nat. Med. 2 12 (1996) 1293-1300
15. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev., Immunol. 3 9 (2003) 710-720
16. Hieshima K., Ohtani H., Shibano M., Izawa D., Nakayama T., Kawasaki Y., Shiba F., Shiota M., Katou F., Saito T., and Yoshie O. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J. Immunol. 170 3 (2003) 1452-1461
17. Hieshima K., Kawasaki Y., Hanamoto H., Nakayama T., Nagakubo D., Kanamaru A., and Yoshie O. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells. J.Immunol. 173 6 (2004) 3668-3675
18. Hill J.M., Shimomura Y., Dudley J.B., Berman E., Haruta Y., Kwon B.S., and Maguire L.J. Timolol induces HSV-1 ocular shedding in the latently infected rabbit. Invest. Ophthalmol. Visual Sci. 28 3 (1987) 585-590
19. Howell M.D., Jones J.F., Kisich K.O., Streib J.E., Gallo R.L., and Leung D.Y. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J. Immunol. 172 3 (2004) 1763-1767
20. Iijima W., Ohtani H., Nakayama T., Sugawara Y., Sato E., Nagura H., Yoshie O., and Sasano T. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism. Am. J. Pathol. 163 1 (2003) 261-268
21. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., and Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91 4 (1997) 521-530
22. Khanna K.M., Lepisto A.J., and Hendricks R.L. Immunity to latent viral infection: many skirmishes but few fatalities. Trends Immunol. 25 5 (2004) 230-234
23. Krijgsveld J., Zaat S.A., Meeldijk J., van Veelen P.A., Fang G., Poolman B., Brandt E., Ehlert J.E., Kuijpers A.J., Engbers G.H., Feijen J., and Dankert J. Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J. Biol. Chem. 275 27 (2000) 20374-20381
24. Kunkel E.J., Kim C.H., Lazarus N.H., Vierra M.A., Soler D., Bowman E.P., and Butcher E.C. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J. Clin. Invest. 111 7 (2003) 1001-1010
25. Laquerre S., Argnani R., Anderson D.B., Zucchini S., Manservigi R., and Glorioso J.C. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J.Virol. 72 7 (1998) 6119-6130
26. Lazarus N.H., Kunkel E.J., Johnston B., Wilson E., Youngman K.R., and Butcher E.C. A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J.Immunol. 170 7 (2003) 3799-3805
27. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev., Immunol. 3 5 (2003) 361-370
28. Marquart M., Bhattacharjee P., Zheng X., Kaufman H., Thompson H., Varnell E., and Hill J. Ocular reactivation phenotype of HSV-1 strain F (MP)E, a corticosteroid-sensitive strain. Curr. Eye Res. 26 3-4 (2003) 205-209
29. Murphy P.M. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2 2 (2001) 116-122
30. Oakes J.E., Rector J.T., and Lausch R.N. Lyt-1+ T cells participate in recovery from ocular herpes simplex virus type 1 infection. Invest. Ophthalmol. Visual Sci. 25 2 (1984) 188-194
31. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J.L., Arenzana-Seisdedos F., Schwartz O., Heard J.M., Clark-Lewis I., Legler D.F., Loetscher M., Baggiolini M., and Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382 6594 (1996) 833-835
32. Ohtani N., Ohtani H., Nakayama T., Naganuma H., Sato E., Imai T., Nagura H., and Yoshie O. Infiltration of CD8+ T cells containing RANTES/CCL5+ cytoplasmic granules in actively inflammatory lesions of human chronic gastritis. Lab. Invest. 84 3 (2004) 368-375
33. Pan J., Kunkel E.J., Gosslar U., Lazarus N., Langdon P., Broadwell K., Vierra M.A., Genovese M.C., Butcher E.C., and Soler D. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J. Immunol. 165 6 (2000) 2943-2949
34. Rosenthal K.L., Smiley J.R., South S., and Johnson D.C. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes. J. Virol. 61 8 (1987) 2438-2447
35. Shirane J., Nakayama T., Nagakubo D., Izawa D., Hieshima K., Shimomura Y., and Yoshie O. Corneal epithelial cells and stromal keratocytes efficiently produce CC chemokine-ligand 20 (CCL20) and attract cells expressing its receptor CCR6 in mouse herpetic stromal keratitis. Curr. Eye Res. 28 5 (2004) 297-306
36. Starner T.D., Barker C.K., Jia H.P., Kang Y., and McCray Jr. P.B. CCL20 is an inducible product of human airway epithelia with innate immune properties. Am. J. Respir. Cell Mol. Biol. 29 5 (2003) 627-633
37. Stievano L., Tosello V., Marcato N., Rosato A., Sebelin A., Chieco-Bianchi L., and Amadori A. CD8+ alpha beta+ T cells that lack surface CD5 antigen expression are a major lymphotactin (XCL1) source in peripheral blood lymphocytes. J. Immunol. 171 9 (2003) 4528-4538
38. Swanson B.J., Murakami M., Mitchell T.C., Kappler J., and Marrack P. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity 17 5 (2002) 605-615
39. Tang Y.Q., Yeaman M.R., and Selsted M.E. Antimicrobial peptides from human platelets. Infect. Immun. 70 12 (2002) 6524-6533
40. Wagner L., Yang O.O., Garcia-Zepeda E.A., Ge Y., Kalams S.A., Walker B.D., Pasternack M.S., and Luster A.D. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391 6670 (1998) 908-911
41. Walzer T., Marcais A., Saltel F., Bella C., Jurdic P., and Marvel J. Cutting edge: immediate RANTES secretion by resting memory CD8 T cells following antigenic stimulation. J. Immunol. 170 4 (2003) 1615-1619
42. Wang W., Soto H., Oldham E.R., Buchanan M.E., Homey B., Catron D., Jenkins N., Copeland N.G., Gilbert D.J., Nguyen N., Abrams J., Kershenovich D., Smith K., McClanahan T., Vicari A.P., and Zlotnik A. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J. Biol. Chem. 275 29 (2000) 22313-22323
43. Wang W., Cole A.M., Hong T., Waring A.J., and Lehrer R.I. Retrocyclin, an antiretroviral theta-defensin, is a lectin. J. Immunol. 170 9 (2003) 4708-4716
44. Wilson E., and Butcher E.C. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J. Exp. Med. 200 6 (2004) 805-809
45. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., Anderson M., Schroder J.M., Wang J.M., Howard O.M., and Oppenheim J.J. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 5439 (1999) 525-528
46. Yang D., Biragyn A., Kwak L.W., and Oppenheim J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23 6 (2002) 291-296
47. Yang D., Chen Q., Hoover D.M., Staley P., Tucker K.D., Lubkowski J., and Oppenheim J.J. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J. Leukocyte Biol. 74 3 (2003) 448-455
48. Yasin B., Wang W., Pang M., Cheshenko N., Hong T., Waring A.J., Herold B.C., Wagar E.A., and Lehrer R.I. Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J.Virol. 78 10 (2004) 5147-5556
49. Yoshie O., Imai T., and Nomiyama H. Chemokines in immunity. Adv. Immunol. 78 (2001) 57-110
50. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 6870 (2002) 389-395
51. Zhang L., Yu W., He T., Yu J., Caffrey R.E., Dalmasso E.A., Fu S., Pham T., Mei J., Ho J.J., Zhang W., Lopez P., and Ho D.D. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298 5595 (2002) 995-1000
52. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 2 (2000) 121-127